Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma

QR Code

Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma

Malignant mesothelioma (MM) is a uniformly fatal tumour caused predominantly by exposure to asbestos. It is not known why some exposed individuals get mesothelioma and others do not. There is some epidemiological evidence of host susceptibility. BAP1 gene somatic mutations and allelic loss are commo...

Full description

Bibliographic Details
Main Authors:	Sneddon, S., Leon, J., Dick, I., Cadby, G., Olsen, N., Brims, F., Allcock, R., Moses, Eric, Melton, P., de Klerk, N., Musk, A., Robinson, B., Creaney, J.
Format:	Journal Article
Published:	2015
Online Access:	http://hdl.handle.net/20.500.11937/26202

Similar Items

Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma
by: Creaney, J., et al.
Published: (2010)

Epidemiology of Malignant Pleural Mesothelioma in Australia
by: De Klerk, N., et al.
Published: (2016)

Asbestos Related non-Malignant Pleural Disease and Mesothelioma
by: Musk, B., et al.
Published: (2016)

Asbestos exposure and histological subtype of malignant mesothelioma
by: Franklin, P., et al.
Published: (2016)

Incidence of malignant mesothelioma in Aboriginal people in Western Australia.
by: Franklin, P., et al.
Published: (2016)

Predicting survival in malignant mesothelioma
by: Musk, A., et al.
Published: (2011)

Validation of an Asbestos Job-Exposure Matrix: Exposure-Response Relationships for Malignant Mesothelioma
by: Kamiya, H., et al.
Published: (2018)

Risk factors for malignant mesothelioma in people with no known exposure to asbestos
by: Musk, B., et al.
Published: (2017)

Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma
by: Muruganandan, S., et al.
Published: (2017)

Prognostic factors for malignant pleural mesothelioma
by: Brims, Fraser, et al.
Published: (2013)

A genome-wide association study for malignant mesothelioma risk
by: Cadby, G., et al.
Published: (2013)

Postmortem findings of malignant pleural mesothelioma: A two-center study of 318 patients
by: Finn, R., et al.
Published: (2012)

Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation
by: Olsen, N., et al.
Published: (2011)

Pattern of malignant mesothelioma incidence and occupational exposure to asbestos in Western Australia.
by: Musk, A., et al.
Published: (2015)

Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia
by: De Klerk, N., et al.
Published: (2013)

Mesothelioma in australia: A review
by: Musk, A., et al.
Published: (2017)

A novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis
by: Brims, Fraser, et al.
Published: (2016)

ROUTINELY COLLECTED CLINICAL AND LABORATORY DATA CAN RELIABLY PREDICT LONGER SURVIVAL IN MALIGNANT PLEURAL MESOTHELIOMA
by: Brims, Fraser, et al.
Published: (2014)

Routinely Collected Clinical And Laboratory Data Can Reliably Predict Longer Survival In Malignant Pleural Mesothelioma
by: Brims, Fraser, et al.
Published: (2014)

SURVIVAL IN MESOTHELIOMA: AN ANALYSIS OF DIFFERENT DIAGNOSTIC TECHNIQUES
by: Muruganandan, S., et al.
Published: (2016)

Wnt Signalling in Malignant Mesothelioma
by: Richards, Alexander S.K.
Published: (2016)

Predicted mortality from malignant mesothelioma among women exposed to blue asbestos at Wittenoom, Western Australia
by: Reid, Alison, et al.
Published: (2009)

Malignant mesotheliomas in former miners and millers of crocidolite at Wittenoom (Western Australia) after more than 50 years follow-up
by: Berry, G., et al.
Published: (2012)

The continual search for ideal biomarkers for mesothelioma: The hurdles
by: Brims, Fraser, et al.
Published: (2013)

Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery.
by: Harris, E., et al.
Published: (2018)

Body composition and nutritional status in malignant pleural mesothelioma: implications for activity levels and quality of life.
by: Jeffery, E., et al.
Published: (2019)

Effect of NSAIDS and COX-2 inhibitors on the incidence and severity of asbestos-induced malignant mesothelioma: Evidence from an animal model and a human cohort
by: Robinson, C., et al.
Published: (2014)

Are children more vulnerable to mesothelioma than adults? A comparison of mesothelioma risk among children and adults exposed non-occupationally to blue asbestos at Wittenoom
by: Reid, Alison, et al.
Published: (2018)

Palliative care in mesothelioma
by: Brims, Fraser
Published: (2018)

MESOTHELIOMA IN AUSTRALIA-RESULTS FROM THE AUSTRALIAN MESOTHELIOMA REGISTRY
by: Sim, M., et al.
Published: (2016)

Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells
by: Fox, Simon, et al.
Published: (2013)

Early specialist palliative care on quality of life for malignant pleural mesothelioma: A randomised controlled trial
by: Brims, Fraser, et al.
Published: (2019)

A Germline MTOR Mutation in Aboriginal Australian Siblings with Intellectual Disability, Dysmorphism, Macrocephaly, and Small Thoraces
by: Baynam, G., et al.
Published: (2015)

Induction of apoptosis in murine malignant mesothelioma cell lines: gene expression and susceptibility
by: Kusmiaty
Published: (2003)

Characterisation of genes derived from murine malignant mesothelioma by suppression subtractive hybridization
by: Thean, Ai Lee
Published: (2002)

A randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma - 'RESPECT-Meso'
by: Brims, Fraser, et al.
Published: (2018)

Retinol supplementation and mesothelioma incidence in workers earlier exposed to blue asbestos (Crocidolite) at Wittenoom, Western Australia
by: Alfonso, Helman, et al.
Published: (2010)

RESPECT-MESO: AN INTERNATIONAL MULTICENTRE NON-BLINDED RANDOMIZED CONTROLLED TRIAL TO ASSESS THE IMPACT OF REGULAR EARLY SPECIALIST PALLIATIVE CARE IN MALIGNANT PLEURAL MESOTHELIOMA
by: Brims, Fraser, et al.
Published: (2017)

Lowdose CT screen-detected malignant and non-malignant findings in a Western Australian Asbestos-exposed cohort: results from the first 5 years of screening
by: Harris, E., et al.
Published: (2018)

Statins do not alter the incidence of mesothelioma in asbestos exposed mice or humans
by: Robinson, C., et al.
Published: (2014)

Cannot write session to /tmp/vufind_sessions/sess_np2iqde98fsdtq36v0m6hs134c